{"gene":"ATP7A","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1995,"finding":"Gene amplification of ATP7A (MNK) in copper-resistant CHO cell variants is associated with increased MNK mRNA and protein (~178 kDa on SDS gels) and enhanced copper efflux, providing direct experimental evidence that ATP7A mediates transmembrane copper efflux.","method":"Southern blot, FISH, SDS-PAGE/immunoblot, copper accumulation assays in copper-resistant CHO cell variants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Southern blot, FISH, immunoblot, functional copper efflux assays), replicated across three independent resistant variants","pmids":["8589689"],"is_preprint":false},{"year":1998,"finding":"ATP7A (MNK) protein localizes primarily to the trans-Golgi network (TGN) under basal copper conditions and redistributes to the cytoplasm and plasma membrane upon elevated extracellular copper, returning to the TGN when copper is reduced; stable cDNA expression in CHO-K1 cells conferred copper resistance proportional to protein levels.","method":"Immunogold electron microscopy, confocal microscopy, immunofluorescence, stable transfection in CHO-K1 cells, copper resistance assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including ultrastructural (immunogold EM) and functional copper resistance assays; replicated across multiple clones","pmids":["9668172"],"is_preprint":false},{"year":1999,"finding":"ATP7A constitutively cycles via the plasma membrane even under basal copper conditions; elevated copper stimulates exocytic movement of ATP7A to the plasma membrane rather than reducing retrieval; a C-terminal di-leucine motif (L1487/L1488) functions as an endocytic signal required for internalization from the plasma membrane.","method":"c-myc epitope tagging within the first extracellular loop; antibody internalization assays in living cells; site-directed mutagenesis of di-leucine motif; co-localization with transferrin","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct topological evidence via extracellular epitope tagging, mutagenesis of endocytic signal, functional internalization assays, multiple orthogonal methods","pmids":["10484781"],"is_preprint":false},{"year":1999,"finding":"In cells from brindled (Mo-br) and blotchy (Mo-blo) mouse mutants (models for Menkes disease and occipital horn syndrome), the Mnk protein shows altered intracellular localization and loss of copper-regulated redistribution; the severity of copper transport defect correlates with the amount of Mnk protein, its intracellular location, and its ability to redistribute in elevated copper.","method":"Copper transport assays, immunofluorescence localization in cultured fibroblasts from mouse mutants","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cell biology with functional copper transport measurements; single lab, two orthogonal methods","pmids":["10332039"],"is_preprint":false},{"year":2001,"finding":"A frameshift mutation in ATP7A exon 23 producing a truncated protein lacking the di-leucine endocytic motif (L1487/L1488) results in occipital horn syndrome rather than classic Menkes disease, supporting that OHS results from lower levels of functional ATP7A and that ATP7A does not require the di-leucine motif for copper efflux per se.","method":"Mutation analysis, transcript quantification, clinical phenotype-genotype correlation","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — genetic/molecular analysis with functional inference; no direct biochemical reconstitution but genotype-phenotype correlation supports mechanistic conclusion","pmids":["11431706"],"is_preprint":false},{"year":2003,"finding":"ATP7A internalization from the plasma membrane is independent of clathrin-mediated endocytosis (dominant-negative dynamin-I, dynamin-II, and Eps15 do not inhibit it) and caveolae-mediated uptake; internalization is inhibited by constitutively active Rac1 GTPase, defining a novel Rac1-regulated endocytic pathway for ATP7A.","method":"Expression of dominant-negative dynamin-I, dynamin-II, Eps15 mutants; caveolae inhibitors; constitutively active Rac1 expression; internalization assays with ATP7A reporter (CD8-MCF1)","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple dominant-negative constructs and pharmacological approaches systematically testing clathrin vs. caveolae vs. Rac1 pathways, with positive and negative controls","pmids":["12812980"],"is_preprint":false},{"year":2004,"finding":"In polarized MDCK epithelial cells, ATP7A relocalizes from the Golgi to the basolateral membrane under elevated copper; N-terminal metal-binding sites are required for copper-regulated Golgi-to-plasma-membrane trafficking; a C-terminal di-leucine motif is critical for basolateral targeting; a putative PDZ target motif is required for basolateral membrane localization in elevated copper.","method":"Confocal microscopy, surface biotinylation, site-directed mutagenesis of trafficking motifs in polarized MDCK cells","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis combined with surface biotinylation and confocal microscopy in physiologically relevant polarized cell model, multiple motifs characterized","pmids":["15269005"],"is_preprint":false},{"year":2004,"finding":"ATP7A endocytosis in HeLa cells is not inhibited by dominant-negative dynamin or Eps15, but is inhibited by hypertonic sucrose, suggesting that MNK can utilize both clathrin-dependent and clathrin-independent endocytosis.","method":"Transient expression of dominant-negative dynamin and Eps15; hypertonic sucrose treatment; internalization assays in MNK-overexpressing HeLa cells","journal":"Biometals","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic and pharmacological perturbations; single lab","pmids":["14977365"],"is_preprint":false},{"year":2007,"finding":"Purified full-length human ATP7A (MNK) reconstituted into liposomes exhibits Cu(I)-dependent ATPase activity (K0.5 = 0.6 µM, Hill coefficient ~5.0), forms a vanadate-sensitive phosphoenzyme intermediate activated by Cu(I) (EC50 = 0.7 µM), and mediates active ATP-dependent vectorial 64Cu transport, demonstrating cooperative Cu(I) interaction in the sub-micromolar range.","method":"Affinity purification from Sf9 insect cells, size-exclusion chromatography, vanadate-sensitive phosphoenzyme assay, ATPase activity assay, 64Cu transport in proteoliposomes","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified full-length protein, direct enzymatic assays (ATPase, phosphoenzyme, vectorial transport), multiple orthogonal biochemical methods","pmids":["17009961"],"is_preprint":false},{"year":2007,"finding":"ATP7A has a role in axonal targeting and synaptogenesis: in the mottled brindled mouse model of Menkes disease, loss of ATP7A disrupts olfactory sensory neuron axonal projections, mitral/tufted cell dendritic growth, synapse integrity, and glomerular organization in the olfactory bulb, demonstrating a developmental requirement for ATP7A (and/or copper) in axon outgrowth.","method":"In vivo immunostaining and morphological analysis of olfactory system in Atp7a(Mobr) mice; developmental expression analysis","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function mouse model with specific neuroanatomical phenotypic readouts; single lab","pmids":["17215139"],"is_preprint":false},{"year":2008,"finding":"ATP7A localizes to melanosomes in a BLOC-1-dependent manner in melanocytes, where it supplies copper to tyrosinase within melanosomes (not merely the TGN), enabling sustained tyrosinase activity and melanin synthesis; BLOC-1 subunit mutations disrupt this ATP7A localization and cause hypopigmentation.","method":"Immunofluorescence co-localization, subcellular fractionation, tyrosinase activity assays, analysis of BLOC-1 mutant melanocytes, live-cell imaging","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (fractionation, co-localization, enzymatic activity, genetic BLOC-1 mutant models) in a high-impact study","pmids":["18650808"],"is_preprint":false},{"year":2011,"finding":"Clusterin and COMMD1 independently interact with ATP7A and regulate its degradation: clusterin promotes ATP7A degradation via the lysosomal pathway, while COMMD1 promotes degradation via the proteasomal pathway; overexpression of either protein decreases endogenous ATP7A, and knockdown increases it.","method":"Co-immunoprecipitation, overexpression and knockdown experiments, lysosomal and proteasomal inhibitor assays, immunoblot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, gain-of-function/loss-of-function, pharmacological pathway dissection with multiple orthogonal approaches in single study","pmids":["22130675"],"is_preprint":false},{"year":2011,"finding":"Two ATP7A missense mutations causing distal motor neuropathy (T994I and P1386S) shift the steady-state distribution of ATP7A to the plasma membrane (exaggerated PM localization) due to impaired endocytic retrieval from the PM to the TGN; ATP7A(T994I) shows abnormal interaction with p97/VCP, and siRNA knockdown of p97/VCP corrects the mislocalization; ATP7A(P1386S) has destabilized insertion of the eighth transmembrane helix.","method":"Total internal reflection fluorescence microscopy, transfection of Venus-tagged mutants in HEK293T and NSC-34 motor neurons, immunoprecipitation, siRNA knockdown, flow cytometry","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (TIRF, co-IP, siRNA rescue, flow cytometry) in relevant cell types; motor neuropathy mechanism directly established","pmids":["22210628"],"is_preprint":false},{"year":2009,"finding":"ATP7A is a target gene of retinoic acid receptor beta2 (RARβ2) in neuroblastoma cells: RARβ2 overexpression upregulates ATP7A expression; RARβ2 siRNA blocks retinoid-induced ATP7A induction; forced downregulation of ATP7A reduces copper efflux and increases cell viability during retinoid treatment.","method":"siRNA knockdown, ectopic overexpression of RARβ2 domains, copper efflux assays, cell viability assays","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with functional copper efflux readout; single lab","pmids":["19127267"],"is_preprint":false},{"year":2017,"finding":"Akt2 (protein kinase B beta) binds ATP7A and phosphorylates it at Ser1424/Ser1463/Ser1466, promoting ATP7A protein stabilization (preventing ubiquitination/degradation) and translocation to the plasma membrane in vascular smooth muscle cells; this stabilization is required for full activation of extracellular SOD3 and protection against endothelial dysfunction in type 2 diabetes.","method":"Immunoprecipitation, in vitro kinase assay, mass spectrometry, Akt2 knockout mice, constitutively active Akt overexpression, ATP7A overexpression rescue, SOD3 activity assays","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay with MS identification of phosphorylation sites, combined with genetic models (Akt2-/-, PTP1B-/-) and functional SOD3 activity rescue","pmids":["29301787"],"is_preprint":false},{"year":2019,"finding":"ATP7A is required for the activity of LOX and LOXL (lysyl oxidase family) copper-dependent enzymes: siRNA silencing of ATP7A inhibits LOX activity in mammary carcinoma cells, resulting in loss of LOX-dependent focal adhesion kinase phosphorylation and reduced myeloid cell lung recruitment; ATP7A silencing also attenuates LOX activity and metastasis of Lewis lung carcinoma cells.","method":"siRNA knockdown, LOX enzymatic activity assays, orthotopic mouse tumor models, FAK phosphorylation assays, lung metastasis quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with direct enzymatic activity readout and in vivo validation in two independent tumor models","pmids":["30890638"],"is_preprint":false},{"year":2020,"finding":"Metallothioneins (MT-I and MT-II) regulate ATP7A trafficking: loss of MTs causes copper-dependent trafficking of ATP7A from the trans-Golgi complex; combined absence of ATP7A and MTs causes synthetic lethality due to extreme copper sensitivity; MTs and ATP7A compete with essential copper-dependent pathways under copper deficiency.","method":"Genetic knockout of ATP7A and/or MT-I/MT-II, confocal immunofluorescence, cell viability assays under copper excess/deficiency","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockouts with trafficking and viability readouts; single lab","pmids":["32398691"],"is_preprint":false},{"year":2021,"finding":"Upon VEGF stimulation, ATP7A translocates from the TGN to the plasma membrane where it binds VEGFR2, preventing autophagy-mediated lysosomal VEGFR2 degradation by inhibiting the autophagic cargo adapter p62/SQSTM1 from binding ubiquitinated VEGFR2; loss of ATP7A in endothelial cells promotes VEGFR2 degradation and impairs angiogenesis.","method":"Inducible EC-specific ATP7A knockout mice, ATP7A-dysfunctional mutant mice, co-immunoprecipitation (ATP7A-VEGFR2), autophagy reporter mice (RFP-EGFP-LC3), VEGFR2 signaling assays, neovascularization assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, multiple genetic mouse models including in vivo autophagy reporter, loss-of-function with mechanistic pathway dissection","pmids":["34035268"],"is_preprint":false},{"year":2021,"finding":"PLEKHA5, PLEKHA6, and PLEKHA7 (WW-PLEKHAs) bind to PDZD11 through their WW domains; PDZD11 interacts with the C-terminus of ATP7A; WW-PLEKHAs recruit PDZD11 to distinct plasma membrane localizations and are required for efficient anterograde targeting of ATP7A to the cell periphery under elevated copper; loss of WW-PLEKHAs or PDZD11 impairs copper extrusion but does not affect ATP7A Golgi localization or copper-induced exit from Golgi.","method":"CRISPR knockout of PLEKHA5/6/7 and PDZD11 in kidney epithelial cells, immunofluorescence microscopy, pull-down assays, bioavailable and total copper measurements, metallothionein-1 expression, cell viability","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO, pull-down, functional copper efflux assays, multiple orthogonal methods in single study","pmids":["34613798"],"is_preprint":false},{"year":2023,"finding":"The adaptor protein-1 (AP-1) complex regulates ATP7A sorting polarity: upon pan-AP-1 knockout, ATP7A loses its trafficking polarity and localizes to both apical and basolateral surfaces under high copper; AP-1A specifically provides directionality and TGN retention for ATP7A; mass spectrometry identified AP-1 as a regulatory partner of ATP7A.","method":"CRISPR knockout of AP-1 isoforms (pan-AP-1, AP-1A, AP-1B), immunofluorescence microscopy, mass spectrometry of regulatory partners, analysis in polarized epithelial cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific CRISPR knockouts with clear trafficking polarity phenotypes, MS-based partner identification, multiple orthogonal approaches","pmids":["38032054"],"is_preprint":false},{"year":2022,"finding":"Protein kinase D (PKD) phosphorylates ATP7A/ATP7B, and PKD inhibition reduces PKD-mediated phosphorylation of ATP7A, leading to enhanced proteasome-mediated degradation of ATP7A; proteasome inhibitor (MG132) reverses the PKD inhibitor effect, indicating phosphorylation by PKD is required for ATP7A stability.","method":"PKD inhibitor (CID2011756), proteasome inhibitor (MG132), immunoblot, RT-PCR in HeLa and HepG2 cells","journal":"Cancer treatment and research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological inhibitors with rescue experiment; mechanistic inference from inhibitor studies without direct kinase assay","pmids":["35908410"],"is_preprint":false},{"year":2017,"finding":"ATP7A is required for influenza A virus replication: knockdown of ATP7A significantly reduced polymerase activity in a minigenome assay and impaired authentic viral RNA synthesis and nucleoprotein/matrix protein accumulation in infected cells.","method":"RNAi knockdown, influenza minigenome assay, viral titer measurements, immunofluorescence for NP localization","journal":"Virology journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with specific functional readout (polymerase activity assay and viral macromolecule synthesis); single lab","pmids":["28115001"],"is_preprint":false},{"year":2009,"finding":"ATP7A downregulation in macrophages by siRNA attenuates cell-mediated LDL oxidation and decreases expression and enzymatic activity of cytosolic phospholipase A2 alpha (cPLA2α); ATP7A transcriptionally regulates cPLA2α promoter activity; cPLA2α overexpression increases LDL oxidation, which is blocked by co-administration of ATP7A siRNA.","method":"siRNA knockdown of ATP7A, LDL oxidation assays, cPLA2α promoter activity assay, cPLA2α enzymatic activity assay, cPLA2α overexpression rescue","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with functional enzymatic and promoter activity readouts; single lab","pmids":["19965596"],"is_preprint":false},{"year":2017,"finding":"ATP7A protein is markedly downregulated in vessels from type 2 diabetes mellitus patients and mouse models; in VSMCs, Akt2 promotes ATP7A stabilization by preventing ubiquitination/degradation and promotes its translocation to the plasma membrane; ATP7A overexpression rescues reduced SOD3 activity in Akt2-/- VSMCs.","method":"Vascular tissue from T2DM patients and db/db mice, Akt2-/- mice, immunoprecipitation, in vitro kinase assay with MS, constitutive active Akt constructs, ATP7A overexpression, SOD3 activity assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay with MS phosphosite identification, genetic mouse models, functional enzyme activity rescue; multiple orthogonal methods","pmids":["29301787"],"is_preprint":false}],"current_model":"ATP7A is a P1B-type copper-transporting ATPase that resides primarily in the trans-Golgi network (TGN) under basal conditions, where it loads copper onto cuproenzymes (including lysyl oxidases, tyrosinase, and dopamine β-hydroxylase) in the secretory pathway; upon elevated intracellular copper, it undergoes copper-stimulated exocytic trafficking to the basolateral plasma membrane (or to melanosomes via a BLOC-1-dependent route) to efflux excess copper, cycling back via a di-leucine (L1487/L1488)-dependent endocytic signal through a Rac1-regulated, largely clathrin-independent pathway; its subcellular targeting is governed by AP-1A (TGN retention and polarity), PDZD11/WW-PLEKHA complexes (peripheral targeting), and Akt2-mediated phosphorylation (stability and PM translocation), while COMMD1 (proteasomal) and clusterin (lysosomal) independently regulate its degradation; its catalytic mechanism involves cooperative Cu(I)-dependent phosphoenzyme formation and vectorial Cu transport; beyond copper homeostasis, ATP7A supplies copper to secreted enzymes (LOX/LOXL, SOD3), interacts with VEGFR2 at the plasma membrane to limit autophagy-mediated VEGFR2 degradation, and its mislocalization to the plasma membrane due to mutations (T994I, P1386S) — driven by aberrant p97/VCP interactions — underlies ATP7A-related distal motor neuropathy."},"narrative":{"mechanistic_narrative":"ATP7A is a P1B-type copper-transporting ATPase that controls cellular copper homeostasis by both metalating cuproenzymes in the secretory pathway and effluxing excess copper across membranes [PMID:8589689, PMID:17009961]. Reconstituted full-length protein exhibits Cu(I)-dependent ATPase activity with strong positive cooperativity, forms a vanadate-sensitive phosphoenzyme intermediate, and mediates active ATP-dependent vectorial copper transport [PMID:17009961]. Under basal copper conditions ATP7A resides predominantly in the trans-Golgi network and constitutively cycles via the plasma membrane; elevated copper stimulates exocytic redistribution to the cell surface, and a C-terminal di-leucine motif (L1487/L1488) drives internalization through a Rac1-regulated, clathrin- and caveolae-independent endocytic route [PMID:9668172, PMID:10484781, PMID:12812980]. In polarized epithelia copper triggers relocation to the basolateral membrane via di-leucine and PDZ-type targeting signals, and in melanocytes ATP7A is delivered to melanosomes in a BLOC-1-dependent manner to supply copper to tyrosinase for melanin synthesis [PMID:15269005, PMID:18650808]. Its trafficking and stability are set by multiple partners: AP-1A confers TGN retention and sorting polarity, WW-PLEKHA/PDZD11 complexes drive anterograde targeting to the cell periphery for copper extrusion, and Akt2-mediated phosphorylation stabilizes the protein and promotes plasma-membrane translocation, whereas clusterin and COMMD1 independently route it to lysosomal and proteasomal degradation [PMID:22130675, PMID:29301787, PMID:34613798, PMID:38032054]. Beyond copper export, ATP7A supplies copper to secreted enzymes including SOD3 and lysyl oxidase family members (LOX/LOXL), supporting extracellular antioxidant defense and tumor-promoting LOX activity, and at the plasma membrane it binds VEGFR2 to limit autophagy-mediated VEGFR2 degradation and sustain angiogenesis [PMID:29301787, PMID:30890638, PMID:34035268]. Loss-of-function and mislocalizing mutations underlie disease: reduced functional ATP7A causes occipital horn syndrome and Menkes-spectrum defects, while the missense mutations T994I and P1386S shift ATP7A to the plasma membrane through impaired endocytic retrieval and aberrant p97/VCP interaction, causing ATP7A-related distal motor neuropathy [PMID:11431706, PMID:22210628].","teleology":[{"year":1995,"claim":"Established that ATP7A is functionally responsible for transmembrane copper efflux, not merely correlated with copper resistance.","evidence":"Gene amplification, immunoblot, and copper accumulation assays in copper-resistant CHO variants","pmids":["8589689"],"confidence":"High","gaps":["Did not resolve the catalytic mechanism or transport directionality","Subcellular site of action unknown"]},{"year":1998,"claim":"Defined the copper-regulated trafficking behavior central to ATP7A function: basal TGN residence with reversible redistribution to the plasma membrane upon copper elevation.","evidence":"Immunogold EM, confocal microscopy, and copper resistance assays in stably transfected CHO-K1 cells","pmids":["9668172"],"confidence":"High","gaps":["Trafficking signals and machinery not identified","Whether redistribution reflects altered exit or retrieval unresolved"]},{"year":1999,"claim":"Resolved that copper stimulates exocytic delivery rather than blocking retrieval and identified the di-leucine motif as the endocytic signal, defining the basis of constitutive cycling.","evidence":"Extracellular epitope tagging, antibody internalization assays, and di-leucine mutagenesis in living cells","pmids":["10484781"],"confidence":"High","gaps":["Endocytic machinery recognizing the motif not identified","Mechanism of copper-stimulated exocytosis unknown"]},{"year":1999,"claim":"Linked ATP7A localization/redistribution capacity to disease severity using Menkes/OHS mouse models, connecting trafficking competence to copper transport phenotype.","evidence":"Copper transport assays and immunofluorescence in brindled and blotchy mutant fibroblasts","pmids":["10332039"],"confidence":"Medium","gaps":["Molecular defects in mutant proteins not biochemically defined","Single-lab cell-based correlation"]},{"year":2001,"claim":"Showed that the di-leucine endocytic motif is dispensable for copper efflux per se and that OHS arises from reduced functional ATP7A levels.","evidence":"Mutation analysis, transcript quantification, and genotype-phenotype correlation","pmids":["11431706"],"confidence":"Medium","gaps":["No biochemical reconstitution of the truncated protein","Quantitative threshold for OHS vs Menkes not defined"]},{"year":2003,"claim":"Defined ATP7A endocytosis as a novel Rac1-regulated, clathrin- and caveolae-independent pathway, distinguishing it from canonical receptor internalization.","evidence":"Dominant-negative dynamin/Eps15, caveolae inhibitors, and constitutively active Rac1 with internalization reporters","pmids":["12812980"],"confidence":"High","gaps":["Rac1 effectors mediating internalization not identified","Apparent conflict with later evidence for clathrin involvement"]},{"year":2004,"claim":"Mapped trafficking signals in polarized epithelia, showing N-terminal metal-binding sites gate copper-regulated Golgi exit while di-leucine and PDZ motifs direct basolateral targeting.","evidence":"Surface biotinylation, confocal microscopy, and motif mutagenesis in polarized MDCK cells","pmids":["15269005"],"confidence":"High","gaps":["PDZ-binding partner not identified at this stage","Did not establish the responsible sorting adaptors"]},{"year":2004,"claim":"Indicated that ATP7A can use both clathrin-dependent and clathrin-independent endocytosis, nuancing the strictly clathrin-independent model.","evidence":"Dominant-negative dynamin/Eps15 and hypertonic sucrose in MNK-overexpressing HeLa cells","pmids":["14977365"],"confidence":"Medium","gaps":["Reconciliation with Rac1-only pathway unresolved","Possible overexpression artifact not excluded"]},{"year":2007,"claim":"Provided definitive biochemical proof of catalytic mechanism: cooperative Cu(I)-dependent ATPase activity, phosphoenzyme formation, and vectorial copper transport by purified protein.","evidence":"Reconstitution of affinity-purified human ATP7A into proteoliposomes with phosphoenzyme, ATPase, and 64Cu transport assays","pmids":["17009961"],"confidence":"High","gaps":["Structural basis of cooperativity not resolved","Number of functional metal-binding sites in catalysis not defined"]},{"year":2007,"claim":"Established a developmental, neuronal requirement for ATP7A in axon outgrowth and synaptogenesis beyond systemic copper supply.","evidence":"Neuroanatomical analysis of the olfactory system in brindled Menkes mouse model","pmids":["17215139"],"confidence":"Medium","gaps":["Cannot separate cell-autonomous ATP7A loss from systemic copper deficiency","Molecular copper-dependent targets in neurons not identified"]},{"year":2008,"claim":"Demonstrated that ATP7A metalates cuproenzymes at their organelle of function, supplying copper to tyrosinase within melanosomes via BLOC-1-dependent delivery.","evidence":"Co-localization, fractionation, tyrosinase activity assays, and BLOC-1 mutant melanocytes","pmids":["18650808"],"confidence":"High","gaps":["How BLOC-1 recruits ATP7A mechanistically not defined","Generality to other cuproenzymes/organelles unaddressed"]},{"year":2009,"claim":"Identified transcriptional and downstream functional roles linking ATP7A to retinoid signaling and macrophage lipid oxidation.","evidence":"RARβ2 gain/loss-of-function with copper efflux and viability assays; ATP7A siRNA with cPLA2α promoter and LDL oxidation assays","pmids":["19127267","19965596"],"confidence":"Medium","gaps":["Mechanism by which ATP7A regulates cPLA2α transcription unclear","Single-lab observations"]},{"year":2011,"claim":"Defined degradation control of ATP7A, with clusterin and COMMD1 routing it to lysosomal and proteasomal pathways respectively.","evidence":"Reciprocal Co-IP, overexpression/knockdown, and pathway-specific inhibitors with immunoblot","pmids":["22130675"],"confidence":"High","gaps":["Whether degradation is copper-state dependent not resolved","Ubiquitin ligase for proteasomal route not identified"]},{"year":2011,"claim":"Established the molecular basis of ATP7A-related distal motor neuropathy: mutations cause exaggerated plasma-membrane accumulation through impaired retrieval and aberrant p97/VCP interaction.","evidence":"TIRF microscopy, co-IP, siRNA rescue, and flow cytometry of Venus-tagged mutants in HEK293T and motor neurons","pmids":["22210628"],"confidence":"High","gaps":["How surface ATP7A causes neuronal toxicity not defined","Role of p97/VCP in normal ATP7A retrieval unclear"]},{"year":2017,"claim":"Defined Akt2-mediated phosphorylation as a stabilization and trafficking signal that couples ATP7A to extracellular SOD3 activity and vascular protection.","evidence":"In vitro kinase assay with MS phosphosite mapping, Akt2-/- mice, and SOD3 activity rescue in VSMCs","pmids":["29301787"],"confidence":"High","gaps":["Direct effect of phosphosites on transport activity not tested","Phosphatase counteracting Akt2 not defined"]},{"year":2017,"claim":"Showed ATP7A is co-opted for influenza A virus replication, supporting viral polymerase activity and RNA synthesis.","evidence":"siRNA knockdown with minigenome polymerase assay and viral protein/RNA quantification","pmids":["28115001"],"confidence":"Medium","gaps":["Whether copper transport or a copper-independent function is required unclear","Direct viral interaction not demonstrated"]},{"year":2019,"claim":"Established ATP7A as essential for LOX/LOXL cuproenzyme activity, linking copper supply to focal-adhesion signaling and tumor metastasis.","evidence":"ATP7A siRNA with LOX activity, FAK phosphorylation, and orthotopic mouse metastasis models","pmids":["30890638"],"confidence":"High","gaps":["Site of LOX metalation by ATP7A not localized","Therapeutic targetability not established"]},{"year":2020,"claim":"Demonstrated functional interplay between metallothioneins and ATP7A in buffering copper, with synthetic lethality upon combined loss.","evidence":"ATP7A and MT-I/II knockouts with trafficking imaging and viability assays under copper stress","pmids":["32398691"],"confidence":"Medium","gaps":["Molecular basis of MT-controlled ATP7A trafficking unclear","Single-lab genetic model"]},{"year":2021,"claim":"Identified a copper-independent signaling role: plasma-membrane ATP7A binds VEGFR2 to block p62/SQSTM1-mediated autophagic degradation and sustain angiogenesis.","evidence":"EC-specific ATP7A knockout and mutant mice, reciprocal co-IP, autophagy reporter mice, and neovascularization assays","pmids":["34035268"],"confidence":"High","gaps":["Whether ATP7A catalytic activity is required for VEGFR2 protection unresolved","Structural basis of ATP7A-VEGFR2 binding undefined"]},{"year":2021,"claim":"Defined the WW-PLEKHA/PDZD11 module as the adaptor system that targets ATP7A to the cell periphery for copper extrusion, fulfilling the earlier-predicted PDZ-dependent targeting.","evidence":"CRISPR knockout of PLEKHA5/6/7 and PDZD11 with pull-downs and copper efflux assays in kidney epithelial cells","pmids":["34613798"],"confidence":"High","gaps":["How the module is regulated by copper status unclear","Relationship to AP-1-dependent sorting not integrated"]},{"year":2022,"claim":"Implicated PKD phosphorylation in maintaining ATP7A stability against proteasomal degradation.","evidence":"PKD and proteasome inhibitor treatments with immunoblot and RT-PCR in HeLa and HepG2 cells","pmids":["35908410"],"confidence":"Medium","gaps":["No direct kinase assay confirming PKD phosphorylation of ATP7A","Phosphosites not mapped"]},{"year":2023,"claim":"Established AP-1A as the adaptor providing ATP7A sorting polarity and TGN retention, completing the sorting-machinery picture.","evidence":"Isoform-specific AP-1 CRISPR knockouts with trafficking imaging and MS partner identification in polarized epithelia","pmids":["38032054"],"confidence":"High","gaps":["Direct AP-1A recognition motif on ATP7A not mapped","Interplay with WW-PLEKHA/PDZD11 targeting unresolved"]},{"year":null,"claim":"How copper status, multiple kinases (Akt2, PKD), and competing adaptor/degradation systems are integrated to set ATP7A localization in real time, and whether its copper-independent VEGFR2 signaling role requires catalytic activity, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified regulatory model linking phosphorylation, adaptors, and degradation","Catalytic requirement for non-canonical (VEGFR2, viral) functions undefined","No high-resolution structure to explain copper-cooperative catalysis and trafficking signals"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[8]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,8]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[8]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,6,19]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,6,12,17]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[10]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,5]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,6,10,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,12]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,14]}],"complexes":[],"partners":["COMMD1","CLU","AKT2","PDZD11","PLEKHA5","PLEKHA7","VEGFR2","VCP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q04656","full_name":"Copper-transporting ATPase 1","aliases":["Copper pump 1","Menkes disease-associated protein"],"length_aa":1500,"mass_kda":163.4,"function":"ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to outward-facing state (PubMed:10419525, PubMed:19453293, PubMed:19917612, PubMed:28389643, PubMed:31283225). Under physiological conditions, at low cytosolic copper concentration, it is localized at the trans-Golgi network (TGN) where it transfers Cu(+) ions to cuproenzymes of the secretory pathway (PubMed:11092760, PubMed:28389643). Upon elevated cytosolic copper concentrations, it relocalizes to the plasma membrane where it is responsible for the export of excess Cu(+) ions (PubMed:10419525, PubMed:28389643). May play a dual role in neuron function and survival by regulating cooper efflux and neuronal transmission at the synapse as well as by supplying Cu(+) ions to enzymes such as PAM, TYR and SOD3 (By similarity) (PubMed:28389643). In the melanosomes of pigmented cells, provides copper cofactor to TYR to form an active TYR holoenzyme for melanin biosynthesis (By similarity)","subcellular_location":"Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q04656/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP7A","classification":"Not Classified","n_dependent_lines":66,"n_total_lines":1208,"dependency_fraction":0.054635761589403975},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP7A","total_profiled":1310},"omim":[{"mim_id":"620009","title":"KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR","url":"https://www.omim.org/entry/620009"},{"mim_id":"614758","title":"DYNACTIN 4; DCTN4","url":"https://www.omim.org/entry/614758"},{"mim_id":"614482","title":"HUPPKE-BRENDEL SYNDROME; HPBDS","url":"https://www.omim.org/entry/614482"},{"mim_id":"610232","title":"ATPase 13A3; ATP13A3","url":"https://www.omim.org/entry/610232"},{"mim_id":"609313","title":"MEDNIK SYNDROME; MEDNIK","url":"https://www.omim.org/entry/609313"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATP7A"},"hgnc":{"alias_symbol":[],"prev_symbol":["MNK"]},"alphafold":{"accession":"Q04656","domains":[{"cath_id":"3.30.70.100","chopping":"9-83","consensus_level":"high","plddt":85.5001,"start":9,"end":83},{"cath_id":"-","chopping":"91-110_118-149","consensus_level":"high","plddt":72.2783,"start":91,"end":149},{"cath_id":"3.30.70.100","chopping":"172-244","consensus_level":"high","plddt":83.963,"start":172,"end":244},{"cath_id":"3.30.70.100","chopping":"277-348","consensus_level":"high","plddt":80.5385,"start":277,"end":348},{"cath_id":"3.30.70.100","chopping":"379-387_408-446","consensus_level":"medium","plddt":86.214,"start":379,"end":446},{"cath_id":"3.30.70.100","chopping":"489-637","consensus_level":"medium","plddt":79.684,"start":489,"end":637},{"cath_id":"2.70.150.10","chopping":"821-917","consensus_level":"medium","plddt":82.1081,"start":821,"end":917},{"cath_id":"3.40.50.1000","chopping":"1013-1050_1234-1424","consensus_level":"medium","plddt":83.6741,"start":1013,"end":1424},{"cath_id":"3.40.1110.10","chopping":"1054-1137_1176-1231","consensus_level":"medium","plddt":82.0456,"start":1054,"end":1231},{"cath_id":"1.20.120","chopping":"638-812","consensus_level":"medium","plddt":75.6131,"start":638,"end":812}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04656","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q04656-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q04656-F1-predicted_aligned_error_v6.png","plddt_mean":73.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP7A","jax_strain_url":"https://www.jax.org/strain/search?query=ATP7A"},"sequence":{"accession":"Q04656","fasta_url":"https://rest.uniprot.org/uniprotkb/Q04656.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q04656/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04656"}},"corpus_meta":[{"pmid":"21221114","id":"PMC_21221114","title":"ATP7A-related copper transport diseases-emerging concepts and future trends.","date":"2011","source":"Nature reviews. Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21221114","citation_count":424,"is_preprint":false},{"pmid":"17531189","id":"PMC_17531189","title":"Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.","date":"2007","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17531189","citation_count":357,"is_preprint":false},{"pmid":"14729967","id":"PMC_14729967","title":"Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14729967","citation_count":263,"is_preprint":false},{"pmid":"18650808","id":"PMC_18650808","title":"Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18650808","citation_count":205,"is_preprint":false},{"pmid":"30890638","id":"PMC_30890638","title":"ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30890638","citation_count":195,"is_preprint":false},{"pmid":"8589689","id":"PMC_8589689","title":"Gene amplification of the Menkes (MNK; ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8589689","citation_count":147,"is_preprint":false},{"pmid":"25225600","id":"PMC_25225600","title":"Mnk kinase pathway: Cellular functions and biological outcomes.","date":"2014","source":"World journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25225600","citation_count":140,"is_preprint":false},{"pmid":"10484781","id":"PMC_10484781","title":"The Menkes protein (ATP7A; MNK) cycles via the plasma membrane both in basal and elevated extracellular copper using a C-terminal di-leucine endocytic signal.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10484781","citation_count":133,"is_preprint":false},{"pmid":"17724079","id":"PMC_17724079","title":"Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17724079","citation_count":129,"is_preprint":false},{"pmid":"25453757","id":"PMC_25453757","title":"Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25453757","citation_count":119,"is_preprint":false},{"pmid":"28674170","id":"PMC_28674170","title":"The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28674170","citation_count":112,"is_preprint":false},{"pmid":"23281160","id":"PMC_23281160","title":"An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/23281160","citation_count":102,"is_preprint":false},{"pmid":"18000748","id":"PMC_18000748","title":"Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins.","date":"2007","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/18000748","citation_count":92,"is_preprint":false},{"pmid":"15269005","id":"PMC_15269005","title":"Signals regulating trafficking of Menkes (MNK; ATP7A) copper-translocating P-type ATPase in polarized MDCK cells.","date":"2004","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15269005","citation_count":91,"is_preprint":false},{"pmid":"23509154","id":"PMC_23509154","title":"Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23509154","citation_count":89,"is_preprint":false},{"pmid":"27527252","id":"PMC_27527252","title":"Tuning Specific Translation in Cancer Metastasis and Synaptic Memory: Control at the MNK-eIF4E Axis.","date":"2016","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27527252","citation_count":85,"is_preprint":false},{"pmid":"33328217","id":"PMC_33328217","title":"MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.","date":"2020","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/33328217","citation_count":75,"is_preprint":false},{"pmid":"17215139","id":"PMC_17215139","title":"ATP7A (Menkes protein) functions in axonal targeting and synaptogenesis.","date":"2007","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/17215139","citation_count":74,"is_preprint":false},{"pmid":"22130675","id":"PMC_22130675","title":"Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22130675","citation_count":74,"is_preprint":false},{"pmid":"9668172","id":"PMC_9668172","title":"Functional analysis and intracellular localization of the human menkes protein (MNK) stably expressed from a cDNA construct in Chinese hamster ovary cells (CHO-K1).","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9668172","citation_count":73,"is_preprint":false},{"pmid":"34035268","id":"PMC_34035268","title":"The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34035268","citation_count":71,"is_preprint":false},{"pmid":"16549268","id":"PMC_16549268","title":"Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment.","date":"2006","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16549268","citation_count":71,"is_preprint":false},{"pmid":"20686366","id":"PMC_20686366","title":"The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival.","date":"2010","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20686366","citation_count":68,"is_preprint":false},{"pmid":"20927323","id":"PMC_20927323","title":"Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.","date":"2010","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20927323","citation_count":68,"is_preprint":false},{"pmid":"7490081","id":"PMC_7490081","title":"Molecular structure of the Menkes disease gene (ATP7A).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7490081","citation_count":67,"is_preprint":false},{"pmid":"18032482","id":"PMC_18032482","title":"MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18032482","citation_count":65,"is_preprint":false},{"pmid":"33917579","id":"PMC_33917579","title":"ATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle.","date":"2021","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/33917579","citation_count":64,"is_preprint":false},{"pmid":"11241493","id":"PMC_11241493","title":"ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11241493","citation_count":63,"is_preprint":false},{"pmid":"28819394","id":"PMC_28819394","title":"A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28819394","citation_count":58,"is_preprint":false},{"pmid":"28164761","id":"PMC_28164761","title":"Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.","date":"2017","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28164761","citation_count":57,"is_preprint":false},{"pmid":"32398691","id":"PMC_32398691","title":"Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32398691","citation_count":57,"is_preprint":false},{"pmid":"28178522","id":"PMC_28178522","title":"MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28178522","citation_count":57,"is_preprint":false},{"pmid":"17588765","id":"PMC_17588765","title":"Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease.","date":"2007","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/17588765","citation_count":55,"is_preprint":false},{"pmid":"12539963","id":"PMC_12539963","title":"Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease.","date":"2002","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12539963","citation_count":54,"is_preprint":false},{"pmid":"10332039","id":"PMC_10332039","title":"Intracellular localization and loss of copper responsiveness of Mnk, the murine homologue of the Menkes protein, in cells from blotchy (Mo blo) and brindled (Mo br) mouse mutants.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10332039","citation_count":51,"is_preprint":false},{"pmid":"29351901","id":"PMC_29351901","title":"XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29351901","citation_count":49,"is_preprint":false},{"pmid":"10079817","id":"PMC_10079817","title":"Mutation spectrum of ATP7A, the gene defective in Menkes disease.","date":"1999","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/10079817","citation_count":48,"is_preprint":false},{"pmid":"21949767","id":"PMC_21949767","title":"Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21949767","citation_count":46,"is_preprint":false},{"pmid":"27289018","id":"PMC_27289018","title":"Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy.","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27289018","citation_count":45,"is_preprint":false},{"pmid":"31590180","id":"PMC_31590180","title":"Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK.","date":"2019","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31590180","citation_count":45,"is_preprint":false},{"pmid":"26165234","id":"PMC_26165234","title":"Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.","date":"2015","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/26165234","citation_count":43,"is_preprint":false},{"pmid":"33892273","id":"PMC_33892273","title":"Progress in developing MNK inhibitors.","date":"2021","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33892273","citation_count":42,"is_preprint":false},{"pmid":"28271598","id":"PMC_28271598","title":"Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A.","date":"2017","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/28271598","citation_count":42,"is_preprint":false},{"pmid":"22210628","id":"PMC_22210628","title":"Altered intracellular localization and valosin-containing protein (p97 VCP) interaction underlie ATP7A-related distal motor neuropathy.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22210628","citation_count":42,"is_preprint":false},{"pmid":"35136028","id":"PMC_35136028","title":"Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35136028","citation_count":42,"is_preprint":false},{"pmid":"29301787","id":"PMC_29301787","title":"Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.","date":"2018","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29301787","citation_count":41,"is_preprint":false},{"pmid":"27307295","id":"PMC_27307295","title":"Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27307295","citation_count":40,"is_preprint":false},{"pmid":"34533957","id":"PMC_34533957","title":"Update on the Development of MNK Inhibitors as Therapeutic Agents.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34533957","citation_count":39,"is_preprint":false},{"pmid":"11431706","id":"PMC_11431706","title":"A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11431706","citation_count":39,"is_preprint":false},{"pmid":"18256539","id":"PMC_18256539","title":"MNK, EIF4E and targeting translation for therapy.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18256539","citation_count":38,"is_preprint":false},{"pmid":"31921404","id":"PMC_31921404","title":"TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.","date":"2020","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/31921404","citation_count":37,"is_preprint":false},{"pmid":"12812980","id":"PMC_12812980","title":"The Menkes disease ATPase (ATP7A) is internalized via a Rac1-regulated, clathrin- and caveolae-independent pathway.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12812980","citation_count":37,"is_preprint":false},{"pmid":"34613798","id":"PMC_34613798","title":"PLEKHA5, PLEKHA6, and PLEKHA7 bind to PDZD11 to target the Menkes ATPase ATP7A to the cell periphery and regulate copper homeostasis.","date":"2021","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/34613798","citation_count":36,"is_preprint":false},{"pmid":"27618366","id":"PMC_27618366","title":"Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion.","date":"2016","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/27618366","citation_count":35,"is_preprint":false},{"pmid":"27159396","id":"PMC_27159396","title":"Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27159396","citation_count":35,"is_preprint":false},{"pmid":"28115001","id":"PMC_28115001","title":"Host Cell Copper Transporters CTR1 and ATP7A are important for Influenza A virus replication.","date":"2017","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/28115001","citation_count":35,"is_preprint":false},{"pmid":"26609108","id":"PMC_26609108","title":"Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.","date":"2015","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/26609108","citation_count":35,"is_preprint":false},{"pmid":"27364770","id":"PMC_27364770","title":"MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.","date":"2016","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/27364770","citation_count":35,"is_preprint":false},{"pmid":"28766096","id":"PMC_28766096","title":"Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy.","date":"2017","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/28766096","citation_count":34,"is_preprint":false},{"pmid":"27094611","id":"PMC_27094611","title":"Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.","date":"2016","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/27094611","citation_count":33,"is_preprint":false},{"pmid":"17009961","id":"PMC_17009961","title":"Purification and membrane reconstitution of catalytically active Menkes copper-transporting P-type ATPase (MNK; ATP7A).","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17009961","citation_count":33,"is_preprint":false},{"pmid":"20664001","id":"PMC_20664001","title":"Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.","date":"2010","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20664001","citation_count":33,"is_preprint":false},{"pmid":"21149447","id":"PMC_21149447","title":"Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21149447","citation_count":32,"is_preprint":false},{"pmid":"26668315","id":"PMC_26668315","title":"Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26668315","citation_count":31,"is_preprint":false},{"pmid":"29323792","id":"PMC_29323792","title":"The retinamide VNLG-152 inhibits f-AR/AR-V7 and MNK-eIF4E signaling pathways to suppress EMT and castration-resistant prostate cancer xenograft growth.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29323792","citation_count":31,"is_preprint":false},{"pmid":"35907138","id":"PMC_35907138","title":"Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/35907138","citation_count":31,"is_preprint":false},{"pmid":"20836889","id":"PMC_20836889","title":"Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.","date":"2010","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/20836889","citation_count":31,"is_preprint":false},{"pmid":"39394530","id":"PMC_39394530","title":"Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling.","date":"2024","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/39394530","citation_count":30,"is_preprint":false},{"pmid":"25634130","id":"PMC_25634130","title":"Novel C-4 heteroaryl 13-cis-retinamide Mnk/AR degrading agents inhibit cell proliferation and migration and induce apoptosis in human breast and prostate cancer cells and suppress growth of MDA-MB-231 human breast and CWR22Rv1 human prostate tumor xenografts in mice.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25634130","citation_count":29,"is_preprint":false},{"pmid":"14977365","id":"PMC_14977365","title":"Studies on endocytic mechanisms of the Menkes copper-translocating P-type ATPase (ATP7A; MNK). Endocytosis of the Menkes protein.","date":"2004","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14977365","citation_count":29,"is_preprint":false},{"pmid":"32712434","id":"PMC_32712434","title":"Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity.","date":"2020","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32712434","citation_count":26,"is_preprint":false},{"pmid":"24754450","id":"PMC_24754450","title":"ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A.","date":"2014","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24754450","citation_count":26,"is_preprint":false},{"pmid":"12372948","id":"PMC_12372948","title":"Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b.","date":"2002","source":"Nephron","url":"https://pubmed.ncbi.nlm.nih.gov/12372948","citation_count":26,"is_preprint":false},{"pmid":"28087669","id":"PMC_28087669","title":"The Role of the p38-MNK-eIF4E Signaling Axis in TNF Production Downstream of the NOD1 Receptor.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28087669","citation_count":26,"is_preprint":false},{"pmid":"28841037","id":"PMC_28841037","title":"Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.","date":"2017","source":"Future medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28841037","citation_count":25,"is_preprint":false},{"pmid":"22370634","id":"PMC_22370634","title":"MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22370634","citation_count":25,"is_preprint":false},{"pmid":"24316150","id":"PMC_24316150","title":"Involvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cells.","date":"2013","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24316150","citation_count":25,"is_preprint":false},{"pmid":"24735419","id":"PMC_24735419","title":"Translational research investigations on ATP7A: an important human copper ATPase.","date":"2014","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24735419","citation_count":24,"is_preprint":false},{"pmid":"33675774","id":"PMC_33675774","title":"MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.","date":"2021","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33675774","citation_count":24,"is_preprint":false},{"pmid":"27462781","id":"PMC_27462781","title":"Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27462781","citation_count":24,"is_preprint":false},{"pmid":"34747666","id":"PMC_34747666","title":"MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.","date":"2021","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/34747666","citation_count":24,"is_preprint":false},{"pmid":"19965596","id":"PMC_19965596","title":"Participation of ATP7A in macrophage mediated oxidation of LDL.","date":"2009","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19965596","citation_count":23,"is_preprint":false},{"pmid":"25431995","id":"PMC_25431995","title":"Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25431995","citation_count":23,"is_preprint":false},{"pmid":"38032054","id":"PMC_38032054","title":"Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B.","date":"2023","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38032054","citation_count":22,"is_preprint":false},{"pmid":"26408454","id":"PMC_26408454","title":"An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis.","date":"2015","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26408454","citation_count":22,"is_preprint":false},{"pmid":"31544610","id":"PMC_31544610","title":"MNK-eIF4E signalling is a highly conserved mechanism for sensory neuron axonal plasticity: evidence from Aplysia californica.","date":"2019","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31544610","citation_count":21,"is_preprint":false},{"pmid":"20574055","id":"PMC_20574055","title":"Differential contribution of the MTOR and MNK pathways to the regulation of mRNA translation in meiotic and postmeiotic mouse male germ cells.","date":"2010","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/20574055","citation_count":20,"is_preprint":false},{"pmid":"30446586","id":"PMC_30446586","title":"Induction of MNK Kinase-dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors.","date":"2018","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30446586","citation_count":20,"is_preprint":false},{"pmid":"19127267","id":"PMC_19127267","title":"ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells.","date":"2009","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19127267","citation_count":20,"is_preprint":false},{"pmid":"16515558","id":"PMC_16515558","title":"Mnk is a negative regulator of cap-dependent translation in Aplysia neurons.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16515558","citation_count":20,"is_preprint":false},{"pmid":"26910782","id":"PMC_26910782","title":"Unveiling new chemical scaffolds as Mnk inhibitors.","date":"2016","source":"Future medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26910782","citation_count":19,"is_preprint":false},{"pmid":"35908410","id":"PMC_35908410","title":"Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).","date":"2022","source":"Cancer treatment and research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35908410","citation_count":19,"is_preprint":false},{"pmid":"26728896","id":"PMC_26728896","title":"Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26728896","citation_count":19,"is_preprint":false},{"pmid":"35481869","id":"PMC_35481869","title":"Circadian activities of the brain MNK-eIF4E signalling axis contribute to diurnal rhythms of some cognitive functions.","date":"2022","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35481869","citation_count":18,"is_preprint":false},{"pmid":"23359369","id":"PMC_23359369","title":"TGFβ-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy.","date":"2013","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23359369","citation_count":18,"is_preprint":false},{"pmid":"27011159","id":"PMC_27011159","title":"Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells.","date":"2016","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27011159","citation_count":18,"is_preprint":false},{"pmid":"28881737","id":"PMC_28881737","title":"Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28881737","citation_count":18,"is_preprint":false},{"pmid":"20084666","id":"PMC_20084666","title":"Developmental changes in the expression of the Atp7a gene in the liver of mice during the postnatal period.","date":"2010","source":"Journal of experimental zoology. Part A, Ecological genetics and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20084666","citation_count":18,"is_preprint":false},{"pmid":"27418099","id":"PMC_27418099","title":"The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27418099","citation_count":17,"is_preprint":false},{"pmid":"28545025","id":"PMC_28545025","title":"Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28545025","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51066,"output_tokens":6391,"usd":0.124532,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15471,"output_tokens":6230,"usd":0.116553,"stage2_stop_reason":"end_turn"},"total_usd":0.241085,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Gene amplification of ATP7A (MNK) in copper-resistant CHO cell variants is associated with increased MNK mRNA and protein (~178 kDa on SDS gels) and enhanced copper efflux, providing direct experimental evidence that ATP7A mediates transmembrane copper efflux.\",\n      \"method\": \"Southern blot, FISH, SDS-PAGE/immunoblot, copper accumulation assays in copper-resistant CHO cell variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Southern blot, FISH, immunoblot, functional copper efflux assays), replicated across three independent resistant variants\",\n      \"pmids\": [\"8589689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ATP7A (MNK) protein localizes primarily to the trans-Golgi network (TGN) under basal copper conditions and redistributes to the cytoplasm and plasma membrane upon elevated extracellular copper, returning to the TGN when copper is reduced; stable cDNA expression in CHO-K1 cells conferred copper resistance proportional to protein levels.\",\n      \"method\": \"Immunogold electron microscopy, confocal microscopy, immunofluorescence, stable transfection in CHO-K1 cells, copper resistance assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including ultrastructural (immunogold EM) and functional copper resistance assays; replicated across multiple clones\",\n      \"pmids\": [\"9668172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ATP7A constitutively cycles via the plasma membrane even under basal copper conditions; elevated copper stimulates exocytic movement of ATP7A to the plasma membrane rather than reducing retrieval; a C-terminal di-leucine motif (L1487/L1488) functions as an endocytic signal required for internalization from the plasma membrane.\",\n      \"method\": \"c-myc epitope tagging within the first extracellular loop; antibody internalization assays in living cells; site-directed mutagenesis of di-leucine motif; co-localization with transferrin\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct topological evidence via extracellular epitope tagging, mutagenesis of endocytic signal, functional internalization assays, multiple orthogonal methods\",\n      \"pmids\": [\"10484781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In cells from brindled (Mo-br) and blotchy (Mo-blo) mouse mutants (models for Menkes disease and occipital horn syndrome), the Mnk protein shows altered intracellular localization and loss of copper-regulated redistribution; the severity of copper transport defect correlates with the amount of Mnk protein, its intracellular location, and its ability to redistribute in elevated copper.\",\n      \"method\": \"Copper transport assays, immunofluorescence localization in cultured fibroblasts from mouse mutants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cell biology with functional copper transport measurements; single lab, two orthogonal methods\",\n      \"pmids\": [\"10332039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A frameshift mutation in ATP7A exon 23 producing a truncated protein lacking the di-leucine endocytic motif (L1487/L1488) results in occipital horn syndrome rather than classic Menkes disease, supporting that OHS results from lower levels of functional ATP7A and that ATP7A does not require the di-leucine motif for copper efflux per se.\",\n      \"method\": \"Mutation analysis, transcript quantification, clinical phenotype-genotype correlation\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — genetic/molecular analysis with functional inference; no direct biochemical reconstitution but genotype-phenotype correlation supports mechanistic conclusion\",\n      \"pmids\": [\"11431706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ATP7A internalization from the plasma membrane is independent of clathrin-mediated endocytosis (dominant-negative dynamin-I, dynamin-II, and Eps15 do not inhibit it) and caveolae-mediated uptake; internalization is inhibited by constitutively active Rac1 GTPase, defining a novel Rac1-regulated endocytic pathway for ATP7A.\",\n      \"method\": \"Expression of dominant-negative dynamin-I, dynamin-II, Eps15 mutants; caveolae inhibitors; constitutively active Rac1 expression; internalization assays with ATP7A reporter (CD8-MCF1)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple dominant-negative constructs and pharmacological approaches systematically testing clathrin vs. caveolae vs. Rac1 pathways, with positive and negative controls\",\n      \"pmids\": [\"12812980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In polarized MDCK epithelial cells, ATP7A relocalizes from the Golgi to the basolateral membrane under elevated copper; N-terminal metal-binding sites are required for copper-regulated Golgi-to-plasma-membrane trafficking; a C-terminal di-leucine motif is critical for basolateral targeting; a putative PDZ target motif is required for basolateral membrane localization in elevated copper.\",\n      \"method\": \"Confocal microscopy, surface biotinylation, site-directed mutagenesis of trafficking motifs in polarized MDCK cells\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis combined with surface biotinylation and confocal microscopy in physiologically relevant polarized cell model, multiple motifs characterized\",\n      \"pmids\": [\"15269005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ATP7A endocytosis in HeLa cells is not inhibited by dominant-negative dynamin or Eps15, but is inhibited by hypertonic sucrose, suggesting that MNK can utilize both clathrin-dependent and clathrin-independent endocytosis.\",\n      \"method\": \"Transient expression of dominant-negative dynamin and Eps15; hypertonic sucrose treatment; internalization assays in MNK-overexpressing HeLa cells\",\n      \"journal\": \"Biometals\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic and pharmacological perturbations; single lab\",\n      \"pmids\": [\"14977365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Purified full-length human ATP7A (MNK) reconstituted into liposomes exhibits Cu(I)-dependent ATPase activity (K0.5 = 0.6 µM, Hill coefficient ~5.0), forms a vanadate-sensitive phosphoenzyme intermediate activated by Cu(I) (EC50 = 0.7 µM), and mediates active ATP-dependent vectorial 64Cu transport, demonstrating cooperative Cu(I) interaction in the sub-micromolar range.\",\n      \"method\": \"Affinity purification from Sf9 insect cells, size-exclusion chromatography, vanadate-sensitive phosphoenzyme assay, ATPase activity assay, 64Cu transport in proteoliposomes\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified full-length protein, direct enzymatic assays (ATPase, phosphoenzyme, vectorial transport), multiple orthogonal biochemical methods\",\n      \"pmids\": [\"17009961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ATP7A has a role in axonal targeting and synaptogenesis: in the mottled brindled mouse model of Menkes disease, loss of ATP7A disrupts olfactory sensory neuron axonal projections, mitral/tufted cell dendritic growth, synapse integrity, and glomerular organization in the olfactory bulb, demonstrating a developmental requirement for ATP7A (and/or copper) in axon outgrowth.\",\n      \"method\": \"In vivo immunostaining and morphological analysis of olfactory system in Atp7a(Mobr) mice; developmental expression analysis\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function mouse model with specific neuroanatomical phenotypic readouts; single lab\",\n      \"pmids\": [\"17215139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ATP7A localizes to melanosomes in a BLOC-1-dependent manner in melanocytes, where it supplies copper to tyrosinase within melanosomes (not merely the TGN), enabling sustained tyrosinase activity and melanin synthesis; BLOC-1 subunit mutations disrupt this ATP7A localization and cause hypopigmentation.\",\n      \"method\": \"Immunofluorescence co-localization, subcellular fractionation, tyrosinase activity assays, analysis of BLOC-1 mutant melanocytes, live-cell imaging\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (fractionation, co-localization, enzymatic activity, genetic BLOC-1 mutant models) in a high-impact study\",\n      \"pmids\": [\"18650808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Clusterin and COMMD1 independently interact with ATP7A and regulate its degradation: clusterin promotes ATP7A degradation via the lysosomal pathway, while COMMD1 promotes degradation via the proteasomal pathway; overexpression of either protein decreases endogenous ATP7A, and knockdown increases it.\",\n      \"method\": \"Co-immunoprecipitation, overexpression and knockdown experiments, lysosomal and proteasomal inhibitor assays, immunoblot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, gain-of-function/loss-of-function, pharmacological pathway dissection with multiple orthogonal approaches in single study\",\n      \"pmids\": [\"22130675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Two ATP7A missense mutations causing distal motor neuropathy (T994I and P1386S) shift the steady-state distribution of ATP7A to the plasma membrane (exaggerated PM localization) due to impaired endocytic retrieval from the PM to the TGN; ATP7A(T994I) shows abnormal interaction with p97/VCP, and siRNA knockdown of p97/VCP corrects the mislocalization; ATP7A(P1386S) has destabilized insertion of the eighth transmembrane helix.\",\n      \"method\": \"Total internal reflection fluorescence microscopy, transfection of Venus-tagged mutants in HEK293T and NSC-34 motor neurons, immunoprecipitation, siRNA knockdown, flow cytometry\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (TIRF, co-IP, siRNA rescue, flow cytometry) in relevant cell types; motor neuropathy mechanism directly established\",\n      \"pmids\": [\"22210628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ATP7A is a target gene of retinoic acid receptor beta2 (RARβ2) in neuroblastoma cells: RARβ2 overexpression upregulates ATP7A expression; RARβ2 siRNA blocks retinoid-induced ATP7A induction; forced downregulation of ATP7A reduces copper efflux and increases cell viability during retinoid treatment.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression of RARβ2 domains, copper efflux assays, cell viability assays\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with functional copper efflux readout; single lab\",\n      \"pmids\": [\"19127267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Akt2 (protein kinase B beta) binds ATP7A and phosphorylates it at Ser1424/Ser1463/Ser1466, promoting ATP7A protein stabilization (preventing ubiquitination/degradation) and translocation to the plasma membrane in vascular smooth muscle cells; this stabilization is required for full activation of extracellular SOD3 and protection against endothelial dysfunction in type 2 diabetes.\",\n      \"method\": \"Immunoprecipitation, in vitro kinase assay, mass spectrometry, Akt2 knockout mice, constitutively active Akt overexpression, ATP7A overexpression rescue, SOD3 activity assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay with MS identification of phosphorylation sites, combined with genetic models (Akt2-/-, PTP1B-/-) and functional SOD3 activity rescue\",\n      \"pmids\": [\"29301787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATP7A is required for the activity of LOX and LOXL (lysyl oxidase family) copper-dependent enzymes: siRNA silencing of ATP7A inhibits LOX activity in mammary carcinoma cells, resulting in loss of LOX-dependent focal adhesion kinase phosphorylation and reduced myeloid cell lung recruitment; ATP7A silencing also attenuates LOX activity and metastasis of Lewis lung carcinoma cells.\",\n      \"method\": \"siRNA knockdown, LOX enzymatic activity assays, orthotopic mouse tumor models, FAK phosphorylation assays, lung metastasis quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with direct enzymatic activity readout and in vivo validation in two independent tumor models\",\n      \"pmids\": [\"30890638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Metallothioneins (MT-I and MT-II) regulate ATP7A trafficking: loss of MTs causes copper-dependent trafficking of ATP7A from the trans-Golgi complex; combined absence of ATP7A and MTs causes synthetic lethality due to extreme copper sensitivity; MTs and ATP7A compete with essential copper-dependent pathways under copper deficiency.\",\n      \"method\": \"Genetic knockout of ATP7A and/or MT-I/MT-II, confocal immunofluorescence, cell viability assays under copper excess/deficiency\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockouts with trafficking and viability readouts; single lab\",\n      \"pmids\": [\"32398691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Upon VEGF stimulation, ATP7A translocates from the TGN to the plasma membrane where it binds VEGFR2, preventing autophagy-mediated lysosomal VEGFR2 degradation by inhibiting the autophagic cargo adapter p62/SQSTM1 from binding ubiquitinated VEGFR2; loss of ATP7A in endothelial cells promotes VEGFR2 degradation and impairs angiogenesis.\",\n      \"method\": \"Inducible EC-specific ATP7A knockout mice, ATP7A-dysfunctional mutant mice, co-immunoprecipitation (ATP7A-VEGFR2), autophagy reporter mice (RFP-EGFP-LC3), VEGFR2 signaling assays, neovascularization assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, multiple genetic mouse models including in vivo autophagy reporter, loss-of-function with mechanistic pathway dissection\",\n      \"pmids\": [\"34035268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PLEKHA5, PLEKHA6, and PLEKHA7 (WW-PLEKHAs) bind to PDZD11 through their WW domains; PDZD11 interacts with the C-terminus of ATP7A; WW-PLEKHAs recruit PDZD11 to distinct plasma membrane localizations and are required for efficient anterograde targeting of ATP7A to the cell periphery under elevated copper; loss of WW-PLEKHAs or PDZD11 impairs copper extrusion but does not affect ATP7A Golgi localization or copper-induced exit from Golgi.\",\n      \"method\": \"CRISPR knockout of PLEKHA5/6/7 and PDZD11 in kidney epithelial cells, immunofluorescence microscopy, pull-down assays, bioavailable and total copper measurements, metallothionein-1 expression, cell viability\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO, pull-down, functional copper efflux assays, multiple orthogonal methods in single study\",\n      \"pmids\": [\"34613798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The adaptor protein-1 (AP-1) complex regulates ATP7A sorting polarity: upon pan-AP-1 knockout, ATP7A loses its trafficking polarity and localizes to both apical and basolateral surfaces under high copper; AP-1A specifically provides directionality and TGN retention for ATP7A; mass spectrometry identified AP-1 as a regulatory partner of ATP7A.\",\n      \"method\": \"CRISPR knockout of AP-1 isoforms (pan-AP-1, AP-1A, AP-1B), immunofluorescence microscopy, mass spectrometry of regulatory partners, analysis in polarized epithelial cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific CRISPR knockouts with clear trafficking polarity phenotypes, MS-based partner identification, multiple orthogonal approaches\",\n      \"pmids\": [\"38032054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Protein kinase D (PKD) phosphorylates ATP7A/ATP7B, and PKD inhibition reduces PKD-mediated phosphorylation of ATP7A, leading to enhanced proteasome-mediated degradation of ATP7A; proteasome inhibitor (MG132) reverses the PKD inhibitor effect, indicating phosphorylation by PKD is required for ATP7A stability.\",\n      \"method\": \"PKD inhibitor (CID2011756), proteasome inhibitor (MG132), immunoblot, RT-PCR in HeLa and HepG2 cells\",\n      \"journal\": \"Cancer treatment and research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological inhibitors with rescue experiment; mechanistic inference from inhibitor studies without direct kinase assay\",\n      \"pmids\": [\"35908410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ATP7A is required for influenza A virus replication: knockdown of ATP7A significantly reduced polymerase activity in a minigenome assay and impaired authentic viral RNA synthesis and nucleoprotein/matrix protein accumulation in infected cells.\",\n      \"method\": \"RNAi knockdown, influenza minigenome assay, viral titer measurements, immunofluorescence for NP localization\",\n      \"journal\": \"Virology journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with specific functional readout (polymerase activity assay and viral macromolecule synthesis); single lab\",\n      \"pmids\": [\"28115001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ATP7A downregulation in macrophages by siRNA attenuates cell-mediated LDL oxidation and decreases expression and enzymatic activity of cytosolic phospholipase A2 alpha (cPLA2α); ATP7A transcriptionally regulates cPLA2α promoter activity; cPLA2α overexpression increases LDL oxidation, which is blocked by co-administration of ATP7A siRNA.\",\n      \"method\": \"siRNA knockdown of ATP7A, LDL oxidation assays, cPLA2α promoter activity assay, cPLA2α enzymatic activity assay, cPLA2α overexpression rescue\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with functional enzymatic and promoter activity readouts; single lab\",\n      \"pmids\": [\"19965596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ATP7A protein is markedly downregulated in vessels from type 2 diabetes mellitus patients and mouse models; in VSMCs, Akt2 promotes ATP7A stabilization by preventing ubiquitination/degradation and promotes its translocation to the plasma membrane; ATP7A overexpression rescues reduced SOD3 activity in Akt2-/- VSMCs.\",\n      \"method\": \"Vascular tissue from T2DM patients and db/db mice, Akt2-/- mice, immunoprecipitation, in vitro kinase assay with MS, constitutive active Akt constructs, ATP7A overexpression, SOD3 activity assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay with MS phosphosite identification, genetic mouse models, functional enzyme activity rescue; multiple orthogonal methods\",\n      \"pmids\": [\"29301787\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP7A is a P1B-type copper-transporting ATPase that resides primarily in the trans-Golgi network (TGN) under basal conditions, where it loads copper onto cuproenzymes (including lysyl oxidases, tyrosinase, and dopamine β-hydroxylase) in the secretory pathway; upon elevated intracellular copper, it undergoes copper-stimulated exocytic trafficking to the basolateral plasma membrane (or to melanosomes via a BLOC-1-dependent route) to efflux excess copper, cycling back via a di-leucine (L1487/L1488)-dependent endocytic signal through a Rac1-regulated, largely clathrin-independent pathway; its subcellular targeting is governed by AP-1A (TGN retention and polarity), PDZD11/WW-PLEKHA complexes (peripheral targeting), and Akt2-mediated phosphorylation (stability and PM translocation), while COMMD1 (proteasomal) and clusterin (lysosomal) independently regulate its degradation; its catalytic mechanism involves cooperative Cu(I)-dependent phosphoenzyme formation and vectorial Cu transport; beyond copper homeostasis, ATP7A supplies copper to secreted enzymes (LOX/LOXL, SOD3), interacts with VEGFR2 at the plasma membrane to limit autophagy-mediated VEGFR2 degradation, and its mislocalization to the plasma membrane due to mutations (T994I, P1386S) — driven by aberrant p97/VCP interactions — underlies ATP7A-related distal motor neuropathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ATP7A is a P1B-type copper-transporting ATPase that controls cellular copper homeostasis by both metalating cuproenzymes in the secretory pathway and effluxing excess copper across membranes [#0, #8]. Reconstituted full-length protein exhibits Cu(I)-dependent ATPase activity with strong positive cooperativity, forms a vanadate-sensitive phosphoenzyme intermediate, and mediates active ATP-dependent vectorial copper transport [#8]. Under basal copper conditions ATP7A resides predominantly in the trans-Golgi network and constitutively cycles via the plasma membrane; elevated copper stimulates exocytic redistribution to the cell surface, and a C-terminal di-leucine motif (L1487/L1488) drives internalization through a Rac1-regulated, clathrin- and caveolae-independent endocytic route [#1, #2, #5]. In polarized epithelia copper triggers relocation to the basolateral membrane via di-leucine and PDZ-type targeting signals, and in melanocytes ATP7A is delivered to melanosomes in a BLOC-1-dependent manner to supply copper to tyrosinase for melanin synthesis [#6, #10]. Its trafficking and stability are set by multiple partners: AP-1A confers TGN retention and sorting polarity, WW-PLEKHA/PDZD11 complexes drive anterograde targeting to the cell periphery for copper extrusion, and Akt2-mediated phosphorylation stabilizes the protein and promotes plasma-membrane translocation, whereas clusterin and COMMD1 independently route it to lysosomal and proteasomal degradation [#11, #14, #18, #19]. Beyond copper export, ATP7A supplies copper to secreted enzymes including SOD3 and lysyl oxidase family members (LOX/LOXL), supporting extracellular antioxidant defense and tumor-promoting LOX activity, and at the plasma membrane it binds VEGFR2 to limit autophagy-mediated VEGFR2 degradation and sustain angiogenesis [#14, #15, #17]. Loss-of-function and mislocalizing mutations underlie disease: reduced functional ATP7A causes occipital horn syndrome and Menkes-spectrum defects, while the missense mutations T994I and P1386S shift ATP7A to the plasma membrane through impaired endocytic retrieval and aberrant p97/VCP interaction, causing ATP7A-related distal motor neuropathy [#4, #12].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that ATP7A is functionally responsible for transmembrane copper efflux, not merely correlated with copper resistance.\",\n      \"evidence\": \"Gene amplification, immunoblot, and copper accumulation assays in copper-resistant CHO variants\",\n      \"pmids\": [\"8589689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the catalytic mechanism or transport directionality\", \"Subcellular site of action unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the copper-regulated trafficking behavior central to ATP7A function: basal TGN residence with reversible redistribution to the plasma membrane upon copper elevation.\",\n      \"evidence\": \"Immunogold EM, confocal microscopy, and copper resistance assays in stably transfected CHO-K1 cells\",\n      \"pmids\": [\"9668172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking signals and machinery not identified\", \"Whether redistribution reflects altered exit or retrieval unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved that copper stimulates exocytic delivery rather than blocking retrieval and identified the di-leucine motif as the endocytic signal, defining the basis of constitutive cycling.\",\n      \"evidence\": \"Extracellular epitope tagging, antibody internalization assays, and di-leucine mutagenesis in living cells\",\n      \"pmids\": [\"10484781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endocytic machinery recognizing the motif not identified\", \"Mechanism of copper-stimulated exocytosis unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Linked ATP7A localization/redistribution capacity to disease severity using Menkes/OHS mouse models, connecting trafficking competence to copper transport phenotype.\",\n      \"evidence\": \"Copper transport assays and immunofluorescence in brindled and blotchy mutant fibroblasts\",\n      \"pmids\": [\"10332039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular defects in mutant proteins not biochemically defined\", \"Single-lab cell-based correlation\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed that the di-leucine endocytic motif is dispensable for copper efflux per se and that OHS arises from reduced functional ATP7A levels.\",\n      \"evidence\": \"Mutation analysis, transcript quantification, and genotype-phenotype correlation\",\n      \"pmids\": [\"11431706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical reconstitution of the truncated protein\", \"Quantitative threshold for OHS vs Menkes not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined ATP7A endocytosis as a novel Rac1-regulated, clathrin- and caveolae-independent pathway, distinguishing it from canonical receptor internalization.\",\n      \"evidence\": \"Dominant-negative dynamin/Eps15, caveolae inhibitors, and constitutively active Rac1 with internalization reporters\",\n      \"pmids\": [\"12812980\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rac1 effectors mediating internalization not identified\", \"Apparent conflict with later evidence for clathrin involvement\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped trafficking signals in polarized epithelia, showing N-terminal metal-binding sites gate copper-regulated Golgi exit while di-leucine and PDZ motifs direct basolateral targeting.\",\n      \"evidence\": \"Surface biotinylation, confocal microscopy, and motif mutagenesis in polarized MDCK cells\",\n      \"pmids\": [\"15269005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PDZ-binding partner not identified at this stage\", \"Did not establish the responsible sorting adaptors\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Indicated that ATP7A can use both clathrin-dependent and clathrin-independent endocytosis, nuancing the strictly clathrin-independent model.\",\n      \"evidence\": \"Dominant-negative dynamin/Eps15 and hypertonic sucrose in MNK-overexpressing HeLa cells\",\n      \"pmids\": [\"14977365\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with Rac1-only pathway unresolved\", \"Possible overexpression artifact not excluded\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided definitive biochemical proof of catalytic mechanism: cooperative Cu(I)-dependent ATPase activity, phosphoenzyme formation, and vectorial copper transport by purified protein.\",\n      \"evidence\": \"Reconstitution of affinity-purified human ATP7A into proteoliposomes with phosphoenzyme, ATPase, and 64Cu transport assays\",\n      \"pmids\": [\"17009961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of cooperativity not resolved\", \"Number of functional metal-binding sites in catalysis not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established a developmental, neuronal requirement for ATP7A in axon outgrowth and synaptogenesis beyond systemic copper supply.\",\n      \"evidence\": \"Neuroanatomical analysis of the olfactory system in brindled Menkes mouse model\",\n      \"pmids\": [\"17215139\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cannot separate cell-autonomous ATP7A loss from systemic copper deficiency\", \"Molecular copper-dependent targets in neurons not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that ATP7A metalates cuproenzymes at their organelle of function, supplying copper to tyrosinase within melanosomes via BLOC-1-dependent delivery.\",\n      \"evidence\": \"Co-localization, fractionation, tyrosinase activity assays, and BLOC-1 mutant melanocytes\",\n      \"pmids\": [\"18650808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BLOC-1 recruits ATP7A mechanistically not defined\", \"Generality to other cuproenzymes/organelles unaddressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified transcriptional and downstream functional roles linking ATP7A to retinoid signaling and macrophage lipid oxidation.\",\n      \"evidence\": \"RARβ2 gain/loss-of-function with copper efflux and viability assays; ATP7A siRNA with cPLA2α promoter and LDL oxidation assays\",\n      \"pmids\": [\"19127267\", \"19965596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which ATP7A regulates cPLA2α transcription unclear\", \"Single-lab observations\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined degradation control of ATP7A, with clusterin and COMMD1 routing it to lysosomal and proteasomal pathways respectively.\",\n      \"evidence\": \"Reciprocal Co-IP, overexpression/knockdown, and pathway-specific inhibitors with immunoblot\",\n      \"pmids\": [\"22130675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether degradation is copper-state dependent not resolved\", \"Ubiquitin ligase for proteasomal route not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the molecular basis of ATP7A-related distal motor neuropathy: mutations cause exaggerated plasma-membrane accumulation through impaired retrieval and aberrant p97/VCP interaction.\",\n      \"evidence\": \"TIRF microscopy, co-IP, siRNA rescue, and flow cytometry of Venus-tagged mutants in HEK293T and motor neurons\",\n      \"pmids\": [\"22210628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How surface ATP7A causes neuronal toxicity not defined\", \"Role of p97/VCP in normal ATP7A retrieval unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined Akt2-mediated phosphorylation as a stabilization and trafficking signal that couples ATP7A to extracellular SOD3 activity and vascular protection.\",\n      \"evidence\": \"In vitro kinase assay with MS phosphosite mapping, Akt2-/- mice, and SOD3 activity rescue in VSMCs\",\n      \"pmids\": [\"29301787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct effect of phosphosites on transport activity not tested\", \"Phosphatase counteracting Akt2 not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed ATP7A is co-opted for influenza A virus replication, supporting viral polymerase activity and RNA synthesis.\",\n      \"evidence\": \"siRNA knockdown with minigenome polymerase assay and viral protein/RNA quantification\",\n      \"pmids\": [\"28115001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether copper transport or a copper-independent function is required unclear\", \"Direct viral interaction not demonstrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established ATP7A as essential for LOX/LOXL cuproenzyme activity, linking copper supply to focal-adhesion signaling and tumor metastasis.\",\n      \"evidence\": \"ATP7A siRNA with LOX activity, FAK phosphorylation, and orthotopic mouse metastasis models\",\n      \"pmids\": [\"30890638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Site of LOX metalation by ATP7A not localized\", \"Therapeutic targetability not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated functional interplay between metallothioneins and ATP7A in buffering copper, with synthetic lethality upon combined loss.\",\n      \"evidence\": \"ATP7A and MT-I/II knockouts with trafficking imaging and viability assays under copper stress\",\n      \"pmids\": [\"32398691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of MT-controlled ATP7A trafficking unclear\", \"Single-lab genetic model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a copper-independent signaling role: plasma-membrane ATP7A binds VEGFR2 to block p62/SQSTM1-mediated autophagic degradation and sustain angiogenesis.\",\n      \"evidence\": \"EC-specific ATP7A knockout and mutant mice, reciprocal co-IP, autophagy reporter mice, and neovascularization assays\",\n      \"pmids\": [\"34035268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ATP7A catalytic activity is required for VEGFR2 protection unresolved\", \"Structural basis of ATP7A-VEGFR2 binding undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the WW-PLEKHA/PDZD11 module as the adaptor system that targets ATP7A to the cell periphery for copper extrusion, fulfilling the earlier-predicted PDZ-dependent targeting.\",\n      \"evidence\": \"CRISPR knockout of PLEKHA5/6/7 and PDZD11 with pull-downs and copper efflux assays in kidney epithelial cells\",\n      \"pmids\": [\"34613798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the module is regulated by copper status unclear\", \"Relationship to AP-1-dependent sorting not integrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Implicated PKD phosphorylation in maintaining ATP7A stability against proteasomal degradation.\",\n      \"evidence\": \"PKD and proteasome inhibitor treatments with immunoblot and RT-PCR in HeLa and HepG2 cells\",\n      \"pmids\": [\"35908410\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct kinase assay confirming PKD phosphorylation of ATP7A\", \"Phosphosites not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established AP-1A as the adaptor providing ATP7A sorting polarity and TGN retention, completing the sorting-machinery picture.\",\n      \"evidence\": \"Isoform-specific AP-1 CRISPR knockouts with trafficking imaging and MS partner identification in polarized epithelia\",\n      \"pmids\": [\"38032054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct AP-1A recognition motif on ATP7A not mapped\", \"Interplay with WW-PLEKHA/PDZD11 targeting unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How copper status, multiple kinases (Akt2, PKD), and competing adaptor/degradation systems are integrated to set ATP7A localization in real time, and whether its copper-independent VEGFR2 signaling role requires catalytic activity, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified regulatory model linking phosphorylation, adaptors, and degradation\", \"Catalytic requirement for non-canonical (VEGFR2, viral) functions undefined\", \"No high-resolution structure to explain copper-cooperative catalysis and trafficking signals\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0046872\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 6, 19]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 6, 12, 17]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 6, 10, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 12]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"COMMD1\", \"CLU\", \"AKT2\", \"PDZD11\", \"PLEKHA5\", \"PLEKHA7\", \"VEGFR2\", \"VCP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}